Synthetic Data: Solving the Clinical Trial Privacy Paradox
The foundation of modern, data-driven medicine rests on high-quality empirical evidence, primarily derived from Randomized Clinical Trials (RCTs). However, sharing the individual patient data (IPD) from these trials is heavily restricted by regulatory frameworks. For example, the EU’s General Data Protection Regulation (GDPR) which aims to protect patient privacy. This "privacy paradox" can hinder innovation, preventing researchers from reusing valuable data to develop predictive models or external control arms.
